本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oncolytics Biotech Inc

1.25
+0.240023.76%
盘后1.20-0.0500-4.00%19:47 EDT
成交量:376.02万
成交额:437.64万
市值:1.11亿
市盈率:-4.50
高:1.27
开:1.03
低:1.00
收:1.01
数据加载中...
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]